世界の動物用診断薬市場：製品、動物、地域別 - 動向および予測
Global Veterinary Diagnostics Market - By Products, By animal types & Geography - Trends & Forecasts- 2015-2020
|発行||Mordor Intelligence LLP||商品コード||319380|
|世界の動物用診断薬市場：製品、動物、地域別 - 動向および予測 Global Veterinary Diagnostics Market - By Products, By animal types & Geography - Trends & Forecasts- 2015-2020|
|出版日: 2016年01月01日||ページ情報: 英文||
The Global Veterinary Diagnostics Market was valued at USD 2.66 billion in 2015 and is projected to reach USD 3.89 billion by 2020, at a CAGR of 7.78% during the forecast period from 2014 to 2019. The ever-rising demand for animal protein and stricter regulations concerning food safety will propel the market for diagnostics in animal healthcare.
Veterinary diagnostic products are as complex as they are difficult to manufacture. Many of the rapid assay, poultry, and livestock diagnostic products are biologic products, which require materials from living organisms. Owing to this, during the economic recession of 2008, the United States faced a decline in consumer spending on pets, which affected the veterinary diagnostics market. The market development for companion animal diagnostics has depended heavily upon the purchasing and usage of in-clinic analyzers or diagnostic instruments that are used for veterinary practices.
Diagnostic technologies, such as lateral flow and other rapid tests are used in veterinary medicine to test commercial livestock and household pets for the presence of a variety of medical conditions to undertake preventative or remedial measures. Food animal diagnostics assist in livestock, production, and animal preventive care while complementing other measures, such as vaccination and selective breeding.
In the global veterinary diagnostics market, molecular diagnostics represents a growing segment of the market with the laboratory utilization of polymerase chain reaction (PCR) and microarray tests.
The North American and European veterinary diagnostics markets have huge market shares owing to the increasing companion animal population coupled with the positive trend towards animal healthcare spending. Developing regions in Asia-pacific and Africa are expected to form a new revenue pocket in the market, with India, China and Brazil constituting a majority of market growth over the next decade.
The global veterinary diagnostics market is segmented by type of products into Enzyme Linked Immuno Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Diagnostic imaging, and Ultrasound Imaging, among others. The market is additionally segmented by type of animals into companion animals and farm animals. The report also covers the market by geography, studying diagnostics in North America, Asia-Pacific, Europe, and the Rest of the World. Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), and Bioniche Animal Health Canada, Inc. (Canada) are the key players in the global veterinary diagnostics market.